Status:

ACTIVE_NOT_RECRUITING

Effectiveness of Contrast-Enhanced Ultrasound

Lead Sponsor:

Children's Hospital of Philadelphia

Conditions:

Abdominal Injuries

Physical Abuse

Eligibility:

All Genders

Up to 7 years

Phase:

PHASE4

Brief Summary

The purpose of the study is to generate pilot data describing test characteristics of contrast enhanced ultrasound in young children with concern for abdominal trauma. The primary objective in this st...

Detailed Description

Abdominal trauma in children can be deadly, but intra-abdominal injuries can be difficult to detect and often lack external signs of injury on physical exam. The current gold standard imaging study is...

Eligibility Criteria

Inclusion

  • Inclusion Criteria for study CEUS
  • Males or females \< 8 years of age at time of enrollment
  • Clinically stable (defined as not undergoing an emergent surgical procedure in the next hour)
  • Abdominal CT ordered or obtained
  • IV in place
  • Exclusion Criteria for study CEUS
  • Unable to obtain contrast-enhanced ultrasound within 72 hours after CT
  • History of allergic reaction to Lumason, sulfa-hexafluoride lipid microsphere components, or other ingredients in Lumason (polyethylene glycol 4000, distearoylphosphatidylcholine (DSPC), dipalmitoylphosphatidylglycerol sodium (DPPG-Na) palmitic acid)
  • Known congenital or acquired heart disease
  • Alternative Inclusion and Exclusion Criteria for children who have undergone or are undergoing CEUS as part of clinical care
  • Inclusion criteria:
  • Males or females \< 8 years of age at time of CEUS.
  • Clinical Team plans to perform CT or has performed CT as part of clinical care for abdominal trauma
  • Clinical Team plans to perform (or has performed) CEUS as part of clinical care
  • Date of CEUS after January 1, 2015
  • Exclusion Criteria: None

Exclusion

    Key Trial Info

    Start Date :

    May 9 2018

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ESTIMATED

    End Date :

    December 1 2026

    Estimated Enrollment :

    120 Patients enrolled

    Trial Details

    Trial ID

    NCT03473249

    Start Date

    May 9 2018

    End Date

    December 1 2026

    Last Update

    December 24 2025

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Children's Hospital of Philadelphia

    Philadelphia, Pennsylvania, United States, 19104